PR

Prestige BioPharma Limited

Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.

950210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Singapore
Address:
21 BIOPOLIS ROAD #04-24 NUCLEOS, SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Prestige BioPharma Limited is a biopharmaceutical company specializing in the development of biosimilars and innovative, first-in-class antibody drugs. The company pursues a dual-track strategy focused on both creating affordable, high-quality biosimilars to enhance patient access and discovering novel therapeutics and vaccines for life-threatening diseases. Its operations cover the full development lifecycle, from discovery and research to clinical development, registration, and commercialization. Prestige BioPharma aims to become a global innovation hub by fostering collaboration and advancing biopharmaceutical technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Prestige BioPharma Limited and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-19 00:00
Audit Report / Information
감사보고서제출
Korean 21.8 KB
2025-09-19 00:00
Annual Report
사업보고서 (2025.06)
Korean 3.7 MB
2025-09-16 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 17.3 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 136.7 KB
2025-09-09 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.5 KB
2025-08-18 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 8.6 KB

Automate Your Workflow. Get a real-time feed of all Prestige BioPharma Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Prestige BioPharma Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany N/A
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875

Talk to a Data Expert

Have a question? We'll get back to you promptly.